Round voting button logo

H.R.8269

CLEAR LABELS Act Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act

Introduced·4/14/26

The CLEAR LABELS Act requires drug labeling to include original manufacturer and supply chain information.

The CLEAR LABELS Act amends the Federal Food, Drug, and Cosmetic Act to mandate that drug labels include the name, place of business, and unique facility identifier of the original manufacturer, packer, or distributor. This information must be accessible through a link, barcode, QR code, or other means to a searchable electronic portal. For finished drug products, labels must also include details of the original manufacturer of each active pharmaceutical ingredient and the original manufacturer of the finished drug product, as well as the packer or distributor.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Ways And Means Committee
Next
Committee decision

Sponsors

D
1
2
RR
Democratic CaucusRepublican Caucus

History

Apr 14

House

Introduced in House

Apr 14

House

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.